Le Voyer TE, Sigurdson ER, Hanlon AL. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 2003;21;2912–2919.
Swanson RS, Compton CC, Stewart AK, Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 2003;10:65–71.
Tepper JE, O'Connell MJ, Niedzwiecki D. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 2001;19:157–163.
Cserni G, Vinh-Hung V, Burzykowski T. Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas? J Surg Oncol 2002;81:63–69.
Fielding LP, Arsenault PA, Chapuis PH. Clinicopathologic staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT). J Gastroenterol Hepatol 1991;6:35–44.
Baxter NN, Virnig DJ, Rothenberger DA. Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst 2005;97:219–225.
Wright FC, Law CH, Last L. Lymph node retrieval and assessment in stage II colorectal cancer: a population based study. Ann Surg Oncol 2003;10:903–909.
Colon and Rectum. In: American Joint Committee on Cancer. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002:113–124.
Taflampas P, Christodoulakis M, Gourtsoyianni S. The effect of preoperative chemoradiotherapy on lymph node harvest after total mesorectal excision for rectal cancer. Dis Colon Rectum 2009;52:1470–1474.
McDonald JR, Renehan AG, O'Dwyer ST, Haboubi NY. Lymph node harvest in colon and rectal cancer: current considerations. World J Gastorintest Surg 2012;4:9–19.
Evans MD, Barton K, Rees A. The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes' stage B disease. Colorectal Dis 2008;10:157–164.
Bilimoria KY, Bentrem DJ, Stewart AK. Lymph node evaluation as a colon cancer quality measure: a national hospital report card. J Natl Cancer Inst 2008;100:1310–1317.
Miller ED, Robb BW, Cummings OW, Johnstone PA. The effects of preoperative chemoradiotherapy on lymph node sampling in rectal cancer. Dis Colon Rectum 2012;55:1002–1007.
Shen SS, Haupt BX, Ro JY. Number of lymph nodes examined and associated clinicopathologic factors in colorectal carcinoma. Arch Pathol Lab Med 2009;133:781–786.
Baxter NN, Morris AM, Rothenberger DA, Tepper JE. Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population–based analysis. Int J Radiat Oncol Biol Phys 2005;61:426–431.
Gorog D, Nagy P, Peter A, Perner F. Influence of obesity on lymph node recovery from rectal cancer specimens. Pathol Oncol Res 2003;9:180–183.
Nathan H, Shore AD, Anders RA. Variation in lymph node assessment after colon cancer resection: patient, surgeon, pathologist, or hospital? J Gastrointest Surg 2011;15:471–479.
Wong SL, Ji H, Hollenbeck BK. Lymph node examination rates and survival after resection for colon cancer. JAMA 2007;298:2149–2154.
Sauer R, Becker H, Hohenberger W. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731–1740.
De la Fuente SG, Manson RJ, Ludwig KA, Mantyh CR. Neoadjuvant chemoradiation for rectal cancer reduces lymph node harvest in proctectomy specimens. J Gastrointest Surg 2009;13:269–274.
Marks JH, Valsdottir EB, Rather AA. Fewer than 12 lymph nodes can be expected in a surgical specimen after high-dose chemoradiation therapy for rectal cancer. Dis Colon Rectum 2010;53:1023–1029.
Rullier A, Laurent C, Capdepont M. Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival. Am J Surg Pathol 2008;32:45–50.
Bosset JF, Calais G, Mineur L. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. Lancet Oncol 2014;15:184–190.
Benson AB, Venook AP, Bekaii-Saab T. NCCN Clinical Practice Guidelines in Oncology: Rectal Cancer. Version 2.2016. Accessed March 28, 2016. To view the most recent version of these guidelines, visit NCCN.org.